Alpna Seth's most recent trade in Bio-Techne Corp was a trade of 3,777 Stock Options (Right to Buy) done . Disclosure was reported to the exchange on Oct. 30, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Bio-Techne | Alpna Seth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 3,777 | 3,777 | - | - | Stock Options (Right to Buy) | |
| Bio-Techne | Alpna Seth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 1,640 | 15,411 (0%) | 0% | 0 | Common Stock | |
| Keros Therapeutics Inc | Alpna Seth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2025 | 10,500 | 10,500 | - | - | Stock Option (right to buy) | |
| Keros Therapeutics Inc | Alpna Seth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2025 | 5,250 | 5,250 | - | 0 | Common Stock | |
| Bio-Techne | Alpna Seth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Oct 2024 | 3,511 | 3,511 | - | - | Stock Options (Right to Buy) | |
| Bio-Techne | Alpna Seth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Oct 2024 | 1,462 | 13,771 (0%) | 0% | 0 | Common Stock | |
| Keros Therapeutics Inc | Alpna Seth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
| Keros Therapeutics Inc | Alpna Seth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
| Seagen Inc | Alpna Seth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 2,044 | 14,997 (0%) | 0% | 0 | Common Stock | |
| Keros Therapeutics Inc | Alpna Seth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2023 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Bio-Techne | Alpna Seth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2022 | 865 | 865 | - | - | Stock Options (Right to Buy) | |
| Bio-Techne | Alpna Seth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2022 | 338 | 2,671 (0%) | 0% | 0 | Common Stock | |
| Seagen Inc | Alpna Seth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2022 | 3,676 | 3,676 | - | - | Non-Qualified Stock Option (right to buy) | |
| Seagen Inc | Alpna Seth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2022 | 1,503 | 12,953 (0%) | 0% | 0 | Common Stock | |
| Bio-Techne | Alpna Seth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Oct 2021 | 633 | 633 | - | - | Stock Option (right to buy) | |
| Bio-Techne | Alpna Seth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Oct 2021 | 194 | 2,333 (0%) | 0% | 0 | Common Stock | |
| Seagen Inc | Alpna Seth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2021 | 3,462 | 3,462 | - | - | Non-Qualified Stock Option (right to buy) | |
| Seagen Inc | Alpna Seth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2021 | 1,402 | 11,450 (0%) | 0% | 0 | Common Stock |